Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Expert Rev Cardiovasc Ther. 2010 Jul;8(7):981-94. doi: 10.1586/erc.10.80.

    Obstructive sleep apnea: novel trigger and potential therapeutic target for cardiac arrhythmias.

    Source

    Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

    Abstract

    Obstructive sleep apnea (OSA), the most common form of sleep-disordered breathing, is prevalent and frequently underdiagnosed in our community. Although presenting with predominantly respiratory symptoms, the most serious complications from OSA are cardiovascular, including arrhythmias, disease of the sinus node and conducting system, and sudden cardiac death. The acute and chronic effects of OSA on the cardiovascular system, which include major effects on autonomic function during sleep and wakefulness, are potent contributors to the development and persistence of cardiac arrhythmias. Although large randomized studies are currently lacking, treatment of OSA may be an important primary or additional therapy to supplement the use of drugs or devices in the treatment of cardiac arrhythmias.

    PMID:
    20602559
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for Atypon

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk